Sign In
Buy BWAY
$14.04
-0.520 (-3.57%)
At Close: Jun 03, 2026
BrainsWay Announces First of its Kind Positive Coverage Policy by Centene for the Treatment of OCD Utilizing Deep TMS™
08:00am, Monday, 24'th May 2021
CRESSKILL, N.J. and JERUSALEM, May 24, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation tr
BrainsWay Ltd. (BWAY) CEO Chris von Jako on Q1 2021 Results - Earnings Call Transcript
11:38am, Thursday, 20'th May 2021
BrainsWay Ltd. (BWAY) CEO Chris von Jako on Q1 2021 Results - Earnings Call Transcript
BrainsWay Reports First Quarter 2021 Financial Results and Operational Highlights
08:00am, Thursday, 20'th May 2021
Strong Revenue Growth of 47% Year-over-Year in Q1 2021
BrainsWay to Present at the Oppenheimer MedTech, Tools & Diagnostics Summit
08:00am, Wednesday, 19'th May 2021
CRESSKILL, N.J. and JERUSALEM, May 19, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatment of br
Should You Buy BrainsWay (BWAY) Ahead of Earnings?
09:47am, Monday, 17'th May 2021
BrainsWay (BWAY) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
BrainsWay Announces Appointment of R. Scott Areglado as Senior Vice President and Chief Financial Officer
08:00am, Wednesday, 05'th May 2021
CRESSKILL, N.J. and JERUSALEM, May 05, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation tr
BrainsWay Announces Launch of Noninvasive Treatment for Smoking Addiction to U.S. Providers
09:03am, Thursday, 29'th Apr 2021
Patients in areas across the country now have access to Deep Transcranial Magnetic Stimulation (Deep TMS) therapy as an aid for short-term smoking cessation Patients in areas across the country now ha
Strength Seen in Brainsway Ltd. Sponsored ADR (BWAY): Can Its 7.3% Jump Turn into More Strength?
06:46am, Tuesday, 27'th Apr 2021
Brainsway Ltd. Sponsored ADR (BWAY) witnessed a jump in share price last session on above-average trading volume.
BWAY Stock: Over 14% Increase Pre-Market Explanation
08:45am, Monday, 26'th Apr 2021
The stock price of Brainsway (NASDAQ: BWAY) increased by over 14% pre-market. This is why it happened.
BrainsWay Receives FDA Clearance for Three-Minute Theta Burst Treatment Protocol for Major Depressive Disorder
07:30am, Monday, 26'th Apr 2021
Shorter Protocol Further Expands Access to Care Shorter Protocol Further Expands Access to Care
BrainsWay Announces 100,000 Patients Treated with Deep Transcranial Magnetic Stimulation (Deep TMS)
09:03am, Wednesday, 14'th Apr 2021
The FDA cleared technology is a noninvasive treatment for depression, OCD, and smoking addiction The FDA cleared technology is a noninvasive treatment for depression, OCD, and smoking addiction
BrainsWay's (BWAY) CEO Christopher von Jako on Q4 2020 Results - Earnings Call Transcript
01:54pm, Thursday, 25'th Mar 2021
BrainsWay's (BWAY) CEO Christopher von Jako on Q4 2020 Results - Earnings Call Transcript
BrainsWay Reports Fourth Quarter and Full-Year 2020 Financial Results and Operational Highlights
04:06pm, Wednesday, 24'th Mar 2021
Conference call to be held tomorrow, March 25, 2021, at 8:30 AM ET Conference call to be held tomorrow, March 25, 2021, at 8:30 AM ET
BrainsWay to Report Fourth Quarter and Full Year 2020 Financial Results on March 25, 2021
07:00am, Thursday, 11'th Mar 2021
CRESSKILL, N.J., March 11, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatment of brain disorder
BrainsWay to Present at the Oppenheimer 31st Annual Healthcare Conference
08:00am, Monday, 08'th Mar 2021
CRESSKILL, N.J. and JERUSALEM, March 08, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of
